Bausch Health Companies BHC Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bausch + Lomb | $5.21B+2.1% | $5.1B+2.5% | $4.98B+1.7% | $4.89B+1.3% | $4.83B+0.8% | |
| Diversified | $917M-2.1% | $937M+3.0% | $910M-1.2% | $921M-3.4% | $953M+0.3% | |
| International | $1.16B+2.0% | $1.13B+2.4% | $1.11B-0.5% | $1.11B+0.2% | $1.11B-0.3% | |
| Salix | $2.68B+3.8% | $2.58B+2.3% | $2.52B+3.0% | $2.45B+2.9% | $2.38B+1.8% | |
| Solta Medical | $576M+11.2% | $518M-0.2% | $519M+5.7% | $491M+5.6% | $465M+5.7% | |
| Operating Income (Loss) by Business | ||||||
| Bausch + Lomb | $1.22B+8.6% | $1.13B+8.4% | $1.04B+1.8% | $1.02B-2.5% | $1.05B-5.6% | |
| Diversified | $612M-2.4% | $627M+3.6% | $605M-1.1% | $612M-4.2% | $639M+2.1% | |
| International | $337M+0.9% | $334M-4.8% | $351M-4.1% | $366M-2.1% | $374M-0.5% | |
| Salix | $2.02B+5.0% | $1.93B+3.7% | $1.86B+7.8% | $1.72B+4.7% | $1.64B+2.6% | |
| Solta Medical | $254M+9.5% | $232M-7.2% | $250M+7.3% | $233M+3.1% | $226M+6.1% | |
| SG&A by Business | ||||||
| Bausch + Lomb | $1.77B-0.4% | $1.78B0.0% | $1.78B+0.5% | $1.77B+2.4% | $1.73B+2.5% | |
| Diversified | $167M-1.2% | $169M+3.0% | $164M+0.6% | $163M-1.8% | $166M-1.8% | |
| International | $247M+4.7% | $236M+6.3% | $222M+1.4% | $219M+2.8% | $213M-0.5% | |
| Salix | $396M-1.5% | $402M-1.7% | $409M-14.3% | $477M+2.1% | $467M+2.0% | |
| Solta Medical | $138M+5.3% | $131M+5.6% | $124M+4.2% | $119M+5.3% | $113M+2.7% | |
| R&D by Business | ||||||
| Bausch + Lomb | $161M+11.8% | $144M+4.3% | $138M+9.5% | $126M+4.1% | $121M0.0% | |
| Diversified | $14M0.0% | $14M0.0% | $14M0.0% | $14M0.0% | $14M-6.7% | |
| International | $27M0.0% | $27M+3.8% | $26M+8.3% | $24M-4.0% | $25M+4.2% | |
| Salix | $81M+2.5% | $79M-3.7% | $82M+2.5% | $80M-10.1% | $89M-10.1% | |
| Solta Medical | $29M+11.5% | $26M0.0% | $26M+18.2% | $22M+15.8% | $19M+5.6% | |
| Additions by Business | ||||||
| Bausch + Lomb | $72.75M-25.0% | $97M-2.8% | $99.75M— | —— | —— | |
| Diversified | $0— | $0— | $0— | —— | —— | |
| International | $0— | $0— | $0— | —— | —— | |
| Salix | $0— | $0— | $0— | —— | —— | |
| Solta Medical | $16.5M-25.0% | $22M+33.3% | $16.5M— | —— | —— | |
| Goodwill, Foreign Currency Translation, Gain (Loss) by Business | ||||||
| Bausch + Lomb | -$83M+43.9% | -$148M-151% | -$59M+41.0% | -$100M-1,211% | $9M-88.9% | |
| International | -$56M+49.1% | -$110M-139% | -$46M— | —— | —— | |
| Salix | $0— | $0— | $0— | $0— | $0— | |
| Solta Medical | $0— | $0— | $0— | $0— | $0— | |
| Goodwill by Business | ||||||
| Bausch + Lomb | $21.78B+0.8% | $21.61B+1.1% | $21.37B+0.4% | $21.29B+0.6% | $21.17B+0.1% | |
| Diversified | $6.61B-2.4% | $6.78B-2.6% | $6.96B-0.1% | $6.96B-0.3% | $6.98B0.0% | |
| International | $3.56B+1.5% | $3.51B+3.1% | $3.4B+1.3% | $3.36B+1.8% | $3.3B-0.9% | |
| Salix | $11.21B-11.3% | $12.64B0.0% | $12.64B0.0% | $12.64B0.0% | $12.64B0.0% | |
| Solta Medical | $504M+4.6% | $482M+4.8% | $460M0.0% | $460M0.0% | $460M0.0% | |
| Goodwill, impairment loss by Business | ||||||
| Bausch + Lomb | $0— | $0— | —— | —— | —— | |
| Diversified | $108.75M-25.0% | $145M— | —— | —— | —— | |
| International | $0— | $0— | —— | —— | —— | |
| Salix | $1.43B— | $0— | —— | —— | —— | |
| Solta Medical | $0— | $0— | —— | —— | —— | |
| Revenue by Product | ||||||
| Other revenues | $102M-7.3% | $110M-2.7% | $113M-3.4% | $117M+1.7% | $115M+7.5% | |
| Price Appreciation Credit | $18M0.0% | $18M-14.3% | $21M+5.0% | $20M0.0% | $20M+11.1% | |
| Product sales | $10.43B+2.7% | $10.16B+2.4% | $9.92B+1.8% | $9.74B+1.3% | $9.62B+1.0% | |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues by Product | ||||||
| Other revenues | $63M-1.6% | $64M-1.5% | $65M+1.6% | $64M+8.5% | $59M+11.3% | |
| Product sales | $2.99B+1.3% | $2.95B+2.5% | $2.88B+1.9% | $2.82B+1.4% | $2.78B+2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
